Literature DB >> 18844577

Endothelin-1 is not predictive of ventricular ectopy or ventricular fibrillation during acute myocardial ischemia.

Atman P Shah1, James T Niemann, Scott Youngquist, Gary Josephson, John P Rosborough.   

Abstract

Endothelin(ET)-1 (ET-1) increases after myocardial infarction and may have effects on myocardial function. ET-1 has also been shown to affect the action potential (AP) which may be arrhythmogenic and predispose to ventricular fibrillation (VF). The effects of ET-2 and ET-3 are uncertain. We hypothesized that the ETs increase during acute ischemia and that plasma levels are predictive of ischemically induced VF. Thirty-four domestic swine underwent balloon occlusion of the proximal LAD coronary artery. Occlusion was confirmed angiographically. Venous samples were collected from the right atrium at baseline and at 5 min intervals for 30 min or until VF induction. ET-1, ET-2, and ET-3 were measured using ELISA. Changes in plasma concentrations were assessed using repeated measures ANOVA with Dunnett's. A p < 0.05 was considered statistically significant. All animals had angiographic evidence of successful proximal LAD occlusion. ET-1 levels were significantly increased from a baseline at 20 min and remained elevated during 30 min of occlusion. ET-2 and ET-3 levels did not change from baseline values (figure, mean +/- SE). VF occurred in 60% of animals. Peak ET-1 values were not significantly different between VF and non-VF animals (6.2 +/- 2.2 vs. 4.8 +/- 2.3 pg/mL). No single ET-1 value had a VF predictive value >50%. There is a significant increase in ET-1 level within 20 min of acute myocardial ischemia. Despite known effects of ET-1 on the AP, this increase did not correlate with the occurrence of VF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18844577      PMCID: PMC2574561          DOI: 10.1089/jir.2008.0026

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  16 in total

1.  Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction.

Authors:  Martine Clozel; Changbin Qiu; Chang-Shen Qiu; Patrick Hess; Jean-Paul Clozel
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

2.  Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction.

Authors:  T Miyauchi; M Yanagisawa; T Tomizawa; Y Sugishita; N Suzuki; M Fujino; R Ajisaka; K Goto; T Masaki
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

3.  The Endothelin-A antagonist LU 135 252 supresses ischemic ventricular extrasystoles and fibrillation in pigs and prevents hypoxic cellular decoupling.

Authors:  M Raschack; F Juchelka; G Rozek-Schaefer
Journal:  J Cardiovasc Pharmacol       Date:  1998       Impact factor: 3.105

4.  Increased plasma endothelin-1 in the early hours of acute myocardial infarction.

Authors:  D J Stewart; G Kubac; K B Costello; P Cernacek
Journal:  J Am Coll Cardiol       Date:  1991-07       Impact factor: 24.094

5.  Changes of endothelin-1 and big endothelin-1 levels and action potential duration during myocardial ischemia-reperfusion in dogs with and without ventricular fibrillation.

Authors:  Hajnalka Vágó; Pál Soós; Endre Zima; László Gellér; Katalin Keltai; Attila Róka; Violetta Kékesi; Alexander Juhász-Nagy; Béla Merkely
Journal:  J Cardiovasc Pharmacol       Date:  2004-11       Impact factor: 3.105

6.  Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects.

Authors:  T Hiramatsu; Y Imai; Y Takanashi; S Hoshino; M Yashima; S A Tanaka; D Chang; M Nakazawa
Journal:  Ann Thorac Surg       Date:  1997-03       Impact factor: 4.330

7.  Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect?

Authors:  T Szabó; L Gellér; B Merkely; L Selmeci; A Juhász-Nagy; F Solti
Journal:  Life Sci       Date:  2000-05-19       Impact factor: 5.037

8.  High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.

Authors:  Elif Elmas; Siegfried Lang; Carl Erik Dempfle; Thorsten Kälsch; Dieter Hannak; Tim Sueselbeck; Christian Wolpert; Martin Borggrefe; Martina Brueckmann
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

9.  Contribution of endogenous endothelin to the extension of myocardial infarct size in rats.

Authors:  T Watanabe; N Suzuki; N Shimamoto; M Fujino; A Imada
Journal:  Circ Res       Date:  1991-08       Impact factor: 17.367

10.  The ET(A) receptor antagonist LU 135252 has no electrophysiological or anti-arrhythmic effects during myocardial ischaemia/reperfusion in dogs.

Authors:  Hajnalka Vágó; Pál Soós; Endre Zima; László Gellér; Violetta Kékesi; Terézia Andrási; Tamás Szabó; Alexander Juhász-Nagy; Béla Merkely
Journal:  Clin Sci (Lond)       Date:  2002-08       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.